Literature DB >> 11752032

Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion.

Ching M Cheung1, Julian R Wright1, Ala'deen E Shurrab1, Hari Mamtora1, Robert N Foley1, Donal J O'Donoghue1, Stephen Waldek1, Philip A Kalra1.   

Abstract

Patients with atherosclerotic renal artery occlusion (RAO) effectively have only a single functioning kidney, so they constitute an ideal group in whom to study the relationship of atherosclerotic renovascular disease (ARVD) severity to renal functional outcome. Of 299 patients with ARVD who had presented to a single center over a 12-yr period, 142 (47.5%) patients with RAO were identified. There was no relationship between baseline renal function and contralateral renovascular anatomy. Patients with contralateral normal, insignificant (<50%), or significant (>50%) renal artery stenoses had baseline creatinine of 243 +/- 235, 292 +/- 197, or 210 +/- 102 micromol/L, respectively, but patients with bilateral RAO (creatinine, 540 +/- 304 micromol/L; P < 0.0001) were significantly worse. There were significant correlations between baseline GFR and both proteinuria (r = -0.32; P < 0.01) and contralateral bipolar renal length (r = 0.44; P < 0.0001). Over a mean follow-up period of 31 +/- 21 (2 to 82) mo, the overall rate of progressive renal functional decline was -4.1 ml/min per yr. Nine patients required dialysis at presentation and a further 15 (10.5%) during the course of the study. There were 85 (59.9%) deaths; median survival of the whole group was 25 mo, and 5-yr survival was 31%. Multivariate analysis indicated that low baseline GFR was the chief variable independently associated with increased probability of death or need of dialysis but that renal vascular anatomy had no prognostic impact. This study reinforces the importance of intrarenal vascular and parenchymal disease in the etiology of renal dysfunction in ARVD.

Entities:  

Mesh:

Year:  2002        PMID: 11752032     DOI: 10.1681/ASN.V131149

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  18 in total

Review 1.  Renovascular hypertension: screening and modern management.

Authors:  Iris Baumgartner; Lilach O Lerman
Journal:  Eur Heart J       Date:  2011-01-27       Impact factor: 29.983

2.  Hypertension and reduced renal function in an 83-year-old patient.

Authors:  Andrea Ungar; Lorella Lambertucci; Chiara Agresti; Riccardo Pini; Maria Boddi; Maria Consuelo Valentini; Gianfranco Parati; Pietro Amedeo Modesti
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 3.  An update on renovascular hypertension.

Authors:  Martin Senitko; Andrew Z Fenves
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

Review 4.  Paradigm Shifts in Atherosclerotic Renovascular Disease: Where Are We Now?

Authors:  Stephen C Textor; Lilach O Lerman
Journal:  J Am Soc Nephrol       Date:  2015-04-13       Impact factor: 10.121

5.  Endothelin-a receptor antagonism after renal angioplasty enhances renal recovery in renovascular disease.

Authors:  Alejandro R Chade; Nathan Tullos; Nicholas J Stewart; Bret Surles
Journal:  J Am Soc Nephrol       Date:  2014-11-06       Impact factor: 10.121

6.  Ultrastructural pathological features of unilateral renal artery stenosis in the rats.

Authors:  Xin Liu; Yonghui Mao; Xuemei He; Mei Wang; Liangying Gan
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 7.  [Hypertension in patients with renal artery stenosis].

Authors:  A Voiculescu; L C Rump
Journal:  Internist (Berl)       Date:  2009-01       Impact factor: 0.743

Review 8.  Darkness at the end of the tunnel: poststenotic kidney injury.

Authors:  Alfonso Eirin; Lilach O Lerman
Journal:  Physiology (Bethesda)       Date:  2013-07

Review 9.  Diagnosis and treatment of renal artery stenosis.

Authors:  Pierre-François Plouin; Liesbeth Bax
Journal:  Nat Rev Nephrol       Date:  2010-01-26       Impact factor: 28.314

10.  An underused opportunity to introduce ACE inhibitors and influence prognosis: observational study of patients undergoing aortic surgery.

Authors:  Kayria Muttardi; Ali Haydar; Chee Kiang Phua; Neil Chapman; Michael Jenkins; Nicholas Jw Cheshire; Colin D Bicknell
Journal:  JRSM Short Rep       Date:  2013-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.